Results 41 to 50 of about 75,041 (164)

Perceived current and future roles of UK-based community pharmacy professionals in the long-term management of acne [PDF]

open access: yes, 2023
Introduction: Acne is a common skin condition treated in community pharmacy but moderate to severe cases may need referral to general practice for treatment that may include topical or oral antimicrobial treatments.
Indira Pillay   +19 more
core   +1 more source

Long‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and MAIC

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A matching‐adjusted indirect treatment comparison (MAIC) was conducted, comparing approved biologics for long‐term (48–52 weeks) treatment of moderate‐to‐severe hidradenitis suppurativa (HS). Using weighted patient‐level trial data allowed re‐estimation of relative bimekizumab efficacy compared with aggregate secukinumab and adalimumab trial data ...
Thrasyvoulos Tzellos   +9 more
wiley   +1 more source

Hidradenitis suppurativa - current and promising non-surgical treatment

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose: Hidradenitis suppurativa (HS) also known as acne inversa is a chronic, inflammatory dermatosis with predilection to apocrine gland-rich regions.
Natalia Baran   +8 more
doaj   +1 more source

Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This systematic review included 38 studies assessing substance‐related and behavioural addictions in patients with chronic inflammatory skin diseases. Nicotine and alcohol use were the most frequently reported addictive behaviours. Addictions were associated with increased disease severity, impaired treatment outcomes and greater psychosocial burden ...
Enya Müller   +5 more
wiley   +1 more source

Surgical View of Morphological and Pathogenetic Identity of Pilonidal Cysts and Acne Inversa [PDF]

open access: yes, 2021
Introduction: As a rule, the treatment of pilonidal cysts is based on a surgical approach. Surgical treatment depends on the form of the disease and surgeon's preferences regarding the method.
Feleshtynskyi, Yaroslav   +3 more
core   +1 more source

Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern   +14 more
wiley   +1 more source

Measuring success in HS treatment from the physician's and the patient's perspective

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis   +4 more
wiley   +1 more source

Advances in the pharmacological treatments for acne inversa

open access: yesPifu-xingbing zhenliaoxue zazhi
Acne inversa, also known as hidradenitis suppurativa, is a refractory chronic inflammatory dermatosis. It is extremely painful in acute phase, while chronic, recurrent attacks can result in disfigurement.
SUN Yuanyuan, YANG Yuying, FU Wenjing
doaj   +1 more source

European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Updated S2k hidradenitis suppurativa (HS) guidelines provide expert consensus on diagnosis, assessment and comorbidities. Expanded substantially since the 2015 version, they reflect rapid growth in HS literature and aim to improve generalist‐level patient care through evidence‐informed, consensus‐based guidance.
G. B. E. Jemec   +36 more
wiley   +1 more source

Therapeutic Inertia in Hidradenitis Suppurativa: Could Defensive Medicine Play a Role?

open access: yes
JEADV Clinical Practice, EarlyView.
Anju George, Alejandro Molina‐Leyva
wiley   +1 more source

Home - About - Disclaimer - Privacy